As the AI surge continues, legal battles are starting to unfold. The New York Times suing Microsoft and OpenAI over copyrighted material. So what’s at stake in this battle of content? And who’s poised to come out on top in the AI race. Plus… weight loss drugs helped pack on the gains for some pharma stocks, but can this trade keep up the hype in 2024?